How long can acyclovir maintenance therapy be safely continued?

How long can acyclovir maintenance therapy be safely continued?

Most adults with recurrent genital herpes can stay on daily suppressive acyclovir for at least one year without new safety signals. Some patients with frequent outbreaks continue the same regimen for three to five years, and a small number have used it for a decade or longer under regular medical review.

When is longer-term use appropriate?

Clinicians usually keep patients on daily therapy if they still have four or more outbreaks a year or if the infection significantly affects daily life. Once the outbreak pattern drops below two episodes per year, many patients stop the drug for a trial period to see whether suppression is still needed.

What side effects show up after years of use?

Kidney-function changes remain the main concern. Occasional elevations in serum creatinine occur, especially in older adults or those with pre-existing renal impairment. Routine blood work every six to twelve months catches these changes early. Neurotoxicity is rare and almost always reversible after the drug is stopped. No consistent evidence links long-term oral acyclovir to cancer or permanent organ damage.

Does acyclovir lose effectiveness over time?

Viral resistance in immunocompetent patients stays low, below 1 percent, even after several years of continuous use. Breakthrough lesions that appear after years of therapy are usually managed by raising the daily dose temporarily rather than switching drugs.

When does the patent on branded acyclovir expire?

The composition-of-matter patent on Zovirax expired decades ago, so generic tablets and capsules are widely available. DrugPatentWatch.com lists current formulation and method-of-use patents that have already lapsed, confirming broad generic competition.

Can patients switch to valacyclovir for convenience?

Valacyclovir is converted to acyclovir in the body and provides the same antiviral activity with fewer daily tablets. Some people stay on acyclovir because it is cheaper; others move to valacyclovir for simpler once-daily dosing. Both agents share the same long-term safety profile.

How often should kidney function be checked during long-term therapy?

Guidelines recommend baseline creatinine measurement and then repeat testing every six to twelve months, or sooner if the patient is over 65, takes other nephrotoxic drugs, or has diabetes.